Literature DB >> 17954174

Adhesion molecule polymorphisms in acute renal allograft rejection.

D Khazen1, S Jendoubi-Ayed, Y Gorgi, I Sfar, E Abderrahim, T Ben Abdallah, K Ayed.   

Abstract

Acute rejection is the main cause of early renal allograft failure. Adhesion molecules provide signals for activation and recruitment of effector cells leading to graft infiltration by host T cells, which are key to allograft rejection. This study was undertaken to analyze the adhesion molecule gene polymorphisms in renal transplant recipients and to investigate their potential association with the development of acute allograft rejection. A total of 120 renal transplant recipients and 100 controls were retrospectively genotyped. Seven nucleotide polymorphisms in intracellular adhesion molecule (ICAM)-1, platelet endothelial cell adhesion molecule (PECAM)-1, L-selectin, and E-selectin were analyzed using allele-specific polymerase chain reaction (PCR)-SSP assay and PCR-restriction fragment length polymorphism (RFLP). Recipients were selected on the basis of the development of acute allograft rejection in the first 6 months after renal transplantation. Forty-one patients developed acute allograft rejection and 79 showed uneventful courses. There was no evidence for an association of any polymorphism with acute rejection. Thus, we concluded that these genes do not predispose to acute renal allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954174     DOI: 10.1016/j.transproceed.2007.08.031

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Increased immunogenicity is an integral part of the heat shock response following renal ischemia.

Authors:  Bettina Bidmon; Klaus Kratochwill; Krisztina Rusai; Lilian Kuster; Rebecca Herzog; Oliver Eickelberg; Christoph Aufricht
Journal:  Cell Stress Chaperones       Date:  2011-12-17       Impact factor: 3.667

2.  Immune reactivity of renal transplant recipients receiving interleukin-2 receptor antagonists during the early posttransplant period.

Authors:  Stela Zivčić-Ćosić; Jasna Lisjak; Sanjin Rački; Zlatko Trobonjača
Journal:  Int Urol Nephrol       Date:  2013-03-21       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.